PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1848010

Lambda YES: a multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations.

S J Elledge·J T Mulligan·S W Ramer·M Spottswood·R W Davis
View original source ↗Export metadata ↓

Abstract

This work describes a multifunctional phage lambda expression vector system, lambda YES, designed to facilitate gene isolation from eukaryotes by complementation of Escherichia coli and Saccharomyces cerevisiae mutations. lambda YES vectors have a selection for cDNA inserts using an oligo adaptor strategy and are capable of expressing genes in both E. coli and S. cerevisiae. They also allow conversion from phage lambda to plasmid clones by using the cre-lox site-specific recombination system, referred to here as automatic subcloning. A simple method has been developed for the conversion of any plasmid into a phage lambda cDNA cloning vector with automatic subcloning capability. cDNA libraries constructed in these vectors were used to isolate genes from humans and Arabidopsis thaliana by complementation of yeast and bacterial mutations, respectively.

Explore related subjects

Antigens, Differentiation, T-LymphocyteBacteriophage lambdaBase SequenceCD28 AntigensCloning, MolecularDNA, ViralEscherichia coliGene LibraryGenesGenetic Complementation TestGenetic VectorsHumansMolecular Sequence DataMutationOligonucleotide ProbesPlantsPlasmidsRestriction MappingSaccharomyces cerevisiaeJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S J Elledge, J T Mulligan, S W Ramer, M Spottswood, R W Davis. 1991-03-01. Lambda YES: a multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations.. https://doi.org/10.1073/pnas.88.5.1731

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Quantitation and phenotyping of T cell clones by flow cytometry.

In order to efficiently analyze large numbers of T cell clones, a method for analysis of small cell cultures by flow cytometry was developed. The aim was to assess cloning efficiency, growth rate and phenotype of T cell clones. The reliability of the flow cytometer for quantitation of cell populations was documented by repeated analysis of manually counted cell samples. In the concentration range from 3000 to 195,000 cells/ml, the correlation coefficient between counts obtained by the flow cytometer and manual cell counts was 0.999 and within-assay coefficients of variation were below 4%. Cell cultures containing less than 200 cells were reliably quantified. The technique was applied for analysis of T cell clonings with different mitogens and in the presence of varying amounts of serum. To reduce time and labour, the cultures were analyzed only 10 days after cloning, when the clones contained less than 100,000 cells. The sensitivity of the flow cytometer in the detection of immunolabeled cells made further expansion of cell cultures unnecessary, thus greatly reducing manual labour and experiment turnover time. The commonly used mitogens phytohemagglutinin (PHA) and the antibody OKT3 resulted in comparable cloning efficiencies and clone sizes. Human serum was essential for high cloning efficiency as well as for continued growth, and could not be substituted with an increased amount of fetal calf serum. When cloning with interleukin-2 at 20,000 U/ml, two growing cell types were identified. The majority of the clones contained CD3+, CD4+, or CD8+ T cells. Ten out of 60 cultures however, contained cells with the CD3-16/56+ NK cell phenotype, indicating that the culture conditions stimulated proliferation of two different cell types. The described method can be applied for rational analysis of large numbers of minute cell cultures, in for example evaluation of different cloning conditions and estimation of precursor cell frequencies in limiting dilution analysis. The simultaneous phenotyping allows precursor cell analysis under conditions that stimulate growth of more than one cell type.

Antigens, Differentiation, T-Lymphocyte↗
PubMed1992

Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

The CD2 accessory molecule mediates an activation pathway in mature T cells, transducing signals similar to those observed following stimulation of the T-cell receptor/CD3 (TCR/CD3) complex. CD2 is also one of the earliest cell surface markers to appear during thymic ontogeny and has been proposed to be a stimulatory pathway for immature thymocytes that have not yet expressed TCRs on their surface (TCR/CD3-). To examine this hypothesis highly purified TCR/CD3- human thymocytes were stimulated using mitogenic combinations of anti-CD2 monoclonal antibodies or individual biotinylated anti-CD2 monoclonal antibodies crosslinked with avidin. TCR/CD3+ thymocytes responded readily to either stimulus as determined by anti-phosphotyrosine immunoblotting, and the pattern of tyrosine phosphorylated substrates was similar to that of mature T cells. In contrast, TCR/CD3- thymocytes responded weakly and with a distinct substrate pattern. In addition, the altered signal transduced by CD2 in TCR/CD3- thymocytes did not lead to a rise in intracellular calcium, failed to induce interleukin 2 receptor expression, and did not serve as a comitogen with phorbol ester or interleukin 2, functions that were all intact in TCR/CD3+ thymocytes. Failure of TCR/CD3- thymocytes to respond to CD2 stimulation was not due to an intrinsic defect in these cells as they responded normally to phorbol ester plus calcium ionophore. In TCR/CD3- thymocytes, CD2 stimulation also failed to affect steady-state mRNA levels of the recombination-activating genes RAG1 and RAG2, whereas in TCR/CD3+ cells activation of the CD2 pathway terminated their expression. Together, these data support the concept that CD2 engagement does not deliver a stimulus to TCR/CD3- thymocytes and suggests that this molecule may not directly participate in the earliest stages of thymic development.

Antigens, Differentiation, T-Lymphocyte↗
PubMed1992

Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.

During physiologic activation of mature CD8+ T cells, TCR and CD8 bind to the same Ag-complexed MHC class I molecule. Thereby, close proximity is induced between CD8 and the TCR/CD3 complex. During this engagement, CD8 may deliver TCR-independent signals via its associated protein tyrosine kinase, p56lck. We studied the potential biologic effects of close association between CD8 and TCR/CD3 complexes by using a bispecific antibody (bsAb) directed against both TCR and CD8 molecules. This hybrid hybridoma (quadroma)-produced bsAb binds as a monomeric molecule to CD3+ CD8+ but not CD3+ CD4+ T cells. The bsAb proved capable of inducing the cytotoxic effector function of cloned CD3+ CD8+ T cells but not of CD3+ CD4+ T cells. When the bsAb was presented to resting T cells by monocytes, proliferation of the CD3+ CD4+ but not the CD3+ CD8+ subset of T lymphocytes was induced. Parental anti-TCR antibody induced vigorous growth of cells of both subsets. Essentially identical results were obtained when bsAb was presented in an immobilized fashion. The unresponsiveness of the CD3+ CD8+ T cells with respect to mitogenesis could be restored by exogenous rIL-2. The data suggest that bsAb-induced activation differs from activation by monospecific anti-TCR antibody. The former appears to more closely mimic physiologic Ag-induced signaling, because it leads to a similar paracrine IL-2-dependent growth pattern. The bsAb may, therefore, be instrumental in studying T cell signaling pathways, in particular the role of CD8-associated p56lck therein.

Antigens, Differentiation, T-Lymphocyte↗